The Europe Plasma Fractionation Market is expected to grow from US$ 6,824.67 million in 2021 to US$ 10,402.95 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028.
Europe Plasma Fractionation Market Introduction
The Europe Plasma Fractionation Market encompasses key countries including Germany, France, the UK, Spain, Italy, and the rest of Europe. The region holds a prominent share in the global plasma fractionation market and is projected to witness robust growth over the forecast period. Key drivers of this market growth include an aging population, rising use of immunoglobulins in treating chronic conditions, increasing prevalence of immune and bleeding disorders, and a growing demand for plasma-derived therapies for disease management.
The medical landscape across Europe is evolving, particularly in the management of chronic conditions such as neurological, hematological, and respiratory disorders. The COVID-19 pandemic significantly influenced healthcare priorities, shifting attention toward critically ill patients and altering disease diagnosis and treatment practices. Many research institutions have redirected efforts toward COVID-19-related studies to better understand the virus. Notably, several federal agencies in Europe supported the use of convalescent plasma therapy for treating COVID-19 patients. For example, France’s National Agency for Medicines and Health Products Safety (ANSM) approved the use of immune plasma therapy for critically ill cases, while the European Commission recommended its emergency application.
Although the adoption of plasma therapies during the pandemic had a positive impact on market awareness and acceptance, it also led to disruptions. The focus on COVID-19 temporarily diverted attention from treating other disorders, such as neurological and hematological diseases. Moreover, pharmaceutical and biopharmaceutical companies prioritized the development of COVID-19 therapies, which somewhat hindered the growth of the plasma fractionation market in other therapeutic areas.
Nevertheless, ongoing investments in research and development by European companies to advance innovative plasma-based treatments, alongside the increasing use of immunoglobulins in diverse therapeutic applications—including neurology, hematology, rare genetic, and autoimmune disorders—are expected to support market expansion. These factors, combined with the rising demand for plasma-derived therapies across Europe, will likely continue to propel the market forward over the coming years.
Europe Plasma Fractionation Market Segmentation
Europe Plasma Fractionation Market -By Product
- Immunoglobulin
- Intravenous Immunoglobulin (IVIG)
- Subcutaneous Immunoglobulin (SCIG)
- Albumin
- Coagulation Factor Concentrates
- Protease Inhibitors
- Other
Europe Plasma Fractionation Market – By Application
- Neurology
- Immunology
- Hematology
- Critical Care
- Pulmonology
- Others
Europe Plasma Fractionation Market – By End User
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Europe Plasma Fractionation Market – By Country
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Europe Plasma Fractionation Market – Company Profiles
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- Sanquin
- SK Plasma
Europe Plasma Fractionation Market Strategic Insights
Strategic insights for the Europe Plasma Fractionation provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Europe Plasma Fractionation Market Regional Insights
The geographic scope of the Europe Plasma Fractionation refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
